Literature DB >> 9326378

Isoform specificity of activators and inhibitors of protein kinase C gamma and delta.

C Keenan1, N Goode, C Pears.   

Abstract

Expression of certain mammalian protein kinase C (PKC) isoforms inhibits the proliferation of Schizosaccharomyces pombe (Goode et al., Mol. Biol. Cell 5 (1994) 907-920). We have taken advantage of this fact to determine the in vivo isoform preference of a number of PKC inhibitors, using a microtitre plate assay which allows rapid screening. This in vivo model has revealed previously unreported preferences; calphostin C is a more efficient inhibitor of the novel PKCS than chelerythrine chloride whereas the efficiencies are reversed for inhibition of the classical PKCgamma. We have also shown that the anti-leukaemic agent bryostatin 1 inhibits or activates in vivo in an isoform-specific manner.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326378     DOI: 10.1016/s0014-5793(97)01104-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Recognition and phagocytosis of apoptotic T cells by resident murine tissue macrophages require multiple signal transduction events.

Authors:  Bin Hu; Antonello Punturieri; Jill Todt; Joanne Sonstein; Timothy Polak; Jeffrey L Curtis
Journal:  J Leukoc Biol       Date:  2002-05       Impact factor: 4.962

2.  Phosphorylation of threonine 154 in p40phox is an important physiological signal for activation of the neutrophil NADPH oxidase.

Authors:  Tamara A M Chessa; Karen E Anderson; Yanhua Hu; Qingbo Xu; Oliver Rausch; Len R Stephens; Phillip T Hawkins
Journal:  Blood       Date:  2010-09-22       Impact factor: 22.113

3.  NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.

Authors:  Jing Yang; Jennifer S Pollock; Pamela K Carmines
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

4.  Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide.

Authors:  Michal Blass; Ilana Kronfeld; Gila Kazimirsky; Peter M Blumberg; Chaya Brodie
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.

Authors:  Zhihong Chen; Lora W Forman; Kenneth A Miller; Brandon English; Asami Takashima; Regine A Bohacek; Robert M Williams; Douglas V Faller
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

6.  Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Einat Deutsch; Adina Cohen; Gila Kazimirsky; Sara Dovrat; Hadara Rubinfeld; Chaya Brodie; Ronit Sarid
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Protein kinase C{gamma} mediates regulation of proliferation by the serotonin 5-hydroxytryptamine receptor 2B.

Authors:  Mira M Wouters; Jaime L Roeder; Vivek S Tharayil; Jennifer E Stanich; Peter R Strege; Sha Lei; Michael R Bardsley; Tamas Ordog; Simon J Gibbons; Gianrico Farrugia
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

8.  Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.

Authors:  S Nimitvilai; D S Arora; M A McElvain; M S Brodie
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

9.  Activation of protein kinase C beta II by the stereo-specific phosphatidylserine receptor is required for phagocytosis of apoptotic thymocytes by resident murine tissue macrophages.

Authors:  Jill C Todt; Bin Hu; Antonello Punturieri; Joanne Sonstein; Timothy Polak; Jeffrey L Curtis
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

10.  Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein.

Authors:  Jin-Ah Park; Anne L Crews; William R Lampe; Shijing Fang; Joungjoa Park; Kenneth B Adler
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.